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characteristics mentioned above. Results: Among our 60
patients, 58 had organ confined disease (8 pT2a: 13%, 6
pT2b:10 %, 41 pT2c: 68%) while 2 patients had extracapsular
invasion (pT3a: 3%), though no seminal vescicle involvement
(pT3b) was detected in this cohort. In 50 cases (83%) the
resection margins were free from cancer (R0), while 10 cases
(17%) showed positive margins (R1). The pathological Gs was
6 in 18 cases (30%), 3+4 in 27 (45%), 4+3 in 14 (23%) and 8-
10 in 1 (2%). According to the risk based analysis, 45 patients
(75%) were at low risk of aggressive disease, while the
percentage of intermediate risk patients was about 23%, and
only 1 patient (2%) harboured a high risk prostate cancer.
Conclusion: According to our study, the inclusion criteria of
Prostate Cancer Research International Active Survelliance
(P.R.I.A.S.) have high accuracy in the prediction of organ
confined and low-intermediate risk prostate cancer. Our results
seem to be consistently better than those of the actual literature,
maybe thanks to the anatomopathological review performed by
a single experienced uropathologist, which allowed us to
exclude 53 patients who would have compromised the accuracy
of our results. Thus, according to our experience, the actual
Active Surveillance parameters can be safely adopted, only if
the review is performed by a single uropathologist of proven
experience.
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Introduction: Recent studies have shown that partial
nephrectomy (PN) has equivalent oncologic outcomes with
radical nephrectomy (RN) for localized renal tumors. The
most recent international guidelines for renal cell carcinoma
(RCC) recommend the use of nephron sparing surgery (NSS)
for renal lesions up to 7 cm in size whenever technically
feasible. Despite this, PN remains underused in North
America. Aim of this study was to evaluate trends in PN use
during the last decade in a north-western Italian region.
Patients and Methods: The regional archives of hospital
discharge records in Piedmont region from January 2000 to
December 2010 were retrospectively analysed. All procedures
recorded with the ICD-9 codes 55.3, 55.4 (PN) and 55.5 (RN)
performed for a primary diagnosis of renal tumor (189.0) were
included in the analysis (n=6180). The surgeries were
performed in 43 different urological institutions, that were
stratified according to academic status and hospital
nephrectomy volume (high >300, intermediate 100-300, low
<100 nephrectomies in the study period). Trends in the use of
PN were assessed overall and according to institution type.
Results: The overall number of surgical procedures for renal
tumors performed in Piedmont region increased significantly
from 2000 to 2010 (+27%). RN is the preferred surgical
treatment, but an increasing use of PN was observed over the
study period. This trend is more significant in centres with
high renal surgical volume (+ 19.9%) and in non academic
centres (+13.7%). Discussion and Conclusion: PN is
increasingly performed in the last decade in Piedmont region.
The most significant increase in the indications to NSS was
observed in institutions with high renal surgical volume.
However, PN remains relatively underused and strategies to
enhance conservative treatments of renal tumors should be
implemented. 
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Introduction: The sensitivity of white light cystoscopy (WLC)
can be improved especially for the detection of flat urothelial
neoplasms. Fluorescent or blue light cystoscopy (BLC) has the
potential to overcome the limitations of WLC. Aim of this
study was to compare the diagnostic accuracy of WLC and
BLC in the diagnosis of urothelial cancer and to identify the
conditions where BLC can provide the highest diagnostic
advantage over WLC. Patients and Methods: 71 patients with
a suspicious primary or recurrent bladder tumor were enrolled
in the study. Patients who had intravesical instillations in the 3
months before the procedure were not eligible. After
intravescical instillation of Hexaminolevulinate 85 mg one
hour before the procedure, the patients underwent WLC
followed by BLC. All observed lesions were reported in a
diagram, biopsied or resected. Detection rate and false
detection rate of the two techniques were compared. Data
were stratified according to pathology of bladder lesions and
bladder site where the lesions were observed. A subset
analysis was also performed to assess the diagnostic accuracy
of WLC and BLC in patients who had (n=36) or had not
(n=35) undergone previous intravesical treatments to prevent
recurrence and progression. Results: Overall 270 bladder
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lesions were detected (102 with BLC, 7 with WLC, 161 with
both techniques). At pathology 236 lesions were malignant,
while 34 were benign. The detection rate was 62.2% for WLC
(147/236) and 98.3% for BLC (232/236). The highest
diagnostic advantage for BLC was observed for the diagnosis
of carcinoma in situ and for lesions located at the bladder
dome. The false detection rate was 12.5% for WLC (21/168)
and 11,4% for BLC (30/263). Overall, 32/71 patients (45.1%)
had a diagnostic advantage with BLC (diagnosis of at least
one Cis, dysplastic or papillary lesion that was missed at
WLC). The subset analysis showed that the detection rate of
BLC is not decreased in patients who have undergone previous
endovesical treatment (98.1% vs. 97.8%), as well as the false
detection rate is not increased (11.6% vs. 11.4%). Discussion
and Conclusion: BLC is a promising technique that has a
significantly higher detection rate than WLC. The highest
diagnostic advantage with BLC can be obtained for the
diagnosis of Cis and of lesions located at the bladder dome.
The detection rate of BLC is not decreased in patients who
underwent previous endovesical treatments when the last
instillation is not performed in the 3 months before the
procedure.
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Purpose: The PSA blood test has changed the epidemiology of
PC, creating a dramatic rise in its incidence and helping to shift
the stage of disease to much earlier and potentially more curable
one. PSA testing remains, however, a source of uncertainties
since periodic testing may increase the risk of treating many
men for screen-detected PC who would not have experienced
ill effects if PC had been left undetected. The risk of over
diagnosis and over treatment associated with PSA is particularly
significant among elderly men, among whom it is questioned
whether life expectancy is significantly reduced after PC
diagnosis. The study aim was to assess, from 1998 thru 2009,
PSA use and PC incidence rates in elderly men (>= 70 years) in
the Friuli Venezia Giulia region (FVG), northeastern Italy.
Methods: PC cases were identified through the population-based
Cancer Registry that collects all cancer cases occurring since
1995 in resident people. Individual history of PSA testing was
extracted from the regional digital health archive that provides
the identification of men tested for PSA and the date of testing.
Joinpoint regression analysis was used to identify significant
changes over time in log-linear slopes. The annual percentage
change (APC) was computed by means of generalised linear
models. Results: From 1998 to 2007, 10377 incident PC cases
have been identified, of which 56.5% were among elderly. The
crude incidence rate of PC in elderly men increased from
824.2/100.000 in 1998 to 875.4 in 2007, with an APC of +6.18
(95%CI 2.01-3.16). 38.826 men (out of the approximately
70300 elderly men residing in FVG) were tested for PSA in
2009, with a total number of 58147 tests performed. Between
1998 and 2009, the percentage of elderly men aged 70-79 who
underwent PSA test increased substantially (APC=13.02%),
with a change in slope in 2002. Among elderly men aged 80
years or older, the APC increase was 12.80%, and 2003 the year
with the change in slope. Approximately 30% of elderly men
who underwent PSA were tested more than once. On average,
there were 1.06 cases of newly diagnosed PC every 100 PSA
tests. The number of elderly men tested for PSA who underwent
ecographic examination and/or biopsy strongly declined -from
900 to 400 ecographic exams for every 10000 tested men; from
300 to 200 biopsy for every 10000 tested men. Conclusion: The
increasing incidence of PC in FVG reflects the rising use of
PSA testing also among elderly men, even for men aged 80
years or older. The huge number of PSA tests was inversely
associated with the number of ecographic examinations or
biopsies over the study period, indicating that PSA testing is
widely used in asymptomatic elderly men.
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Aim: The aim of the study is to evaluate the efficacy of
time/intensity curves (T/IS) for quantitative analysis of
contrast kinetics during contrast-enhanced ultrasound (CEUS)
in characterization of renal lesions. Patients and Methods: We
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